RhumbLine Advisers’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-68,156
| Closed | -$66.8K | – | 4234 |
|
|
2025
Q1 | $66.8K | Buy |
68,156
+305
| +0.4% | +$299 | ﹤0.01% | 3501 |
|
|
2024
Q4 | $106K | Buy |
67,851
+3,423
| +5% | +$5.34K | ﹤0.01% | 3463 |
|
|
2024
Q3 | $236K | Sell |
64,428
-859
| -1% | -$3.15K | ﹤0.01% | 3152 |
|
|
2024
Q2 | $216K | Buy |
+65,287
| New | +$216K | ﹤0.01% | 3188 |
|